Daniel Bu

Jul 22, 2020 | Trainee Corner

Daniel Bu: Using health policy simulation models to forecast the health and economic impact of a sugar-sweetened beverage tax.  Microsimulation models (MSMs) for health outcomes simulate individual event histories associated with key components of a disease process; these simulated life histories can be aggregated to estimate population-level effects of treatment on disease outcomes and are increasingly being used to provide information to guide health policy decisions to meaningfully impact the health of society. For his thesis research, Daniel Bu, candidate for MD/MSCR 2021 and current NRSA TL1 Scholar, has used and adapted a previously validated microsimulation Cardiovascular Disease Policy Model for the study of public policy impact within R 3.6.1.  He works with the Health Policy Modeling Lab to combine nonlinear behavioral economic insights derived from agent-based modeling to individual-level simulations of policy impact aggregated in the hundreds of thousands in validated models. He has used this approach to evaluate the impact of specific tax policies to reduce sugar consumption. Sugar-sweetened beverages (SSB) are currently the single largest source of added sugar in the US diet, and national consumption remains high. Evidence suggests that a high sugar consumption increases the risk of coronary heart disease, stroke, and diabetes. To date, excise taxes have been proposed by international bodies such as the WHO, and implemented in several US jurisdictions. While reductions in SSB consumption have been reported in several places where taxes have been implemented, it is unclear what the long term health and economic impact an SSB tax could have within the demographically and socioeconomically diverse NYC. Additionally, the impact of varying tax structures remains unknown. The results of his studies to date, have been selected as a podium presentation at the 2020 American Heart Association Epidemiology Annual Meeting, an oral presentation at the 2020 New York City Epidemiology Forum (NYCEF) and is currently under review for publication. Under this NRSA TL1 grant, Daniel has also published and presented microsimulation models in the cost-effective use of innovation in otolaryngology, and the efficient allocation of global surgery resources within developing health systems. These studies have significant potential to improve human health through rationale scientifically grounded health policy development and implementation. Daniel’s mentor is Yan Li, PhD, Associate Professor and the Director of the Health Policy Modeling Lab in the Department of Population Health Science and Policy.

Recent ConduITS News

What does the Innovation Core do?

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a commercially viable product, or to recognize the potential for commercialization. i3 Prism i3 Prism is an early-stage...

read more

What is the Innovation Core?

Mount Sinai’s Innovation Partners (MSIP) is the technology commercialization arm of the Mount Sinai Health System, responsible for driving the real-world application of Mount Sinai discoveries and inventions, and the development of research partnerships with industry....

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more